indapamide has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borghi, C; Bortolotto, LA; Degli Esposti, L; Jayagopal, PB; Konradi, A; Perrone, V; Snyman, JR | 1 |
| Borghi, C; Bortolotto, LA; Degli Esposti, L; Jayagopal, PB; Konradi, AO; Perrone, V; Snyman, JR | 1 |
2 other study(ies) available for indapamide and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Leukemia, Myeloid, Acute; Medication Adherence; Perindopril; Retrospective Studies | 2023 |
A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Health Care Costs; Humans; Hypertension; Indapamide; Leukemia, Myeloid, Acute; Medication Adherence; Perindopril; Retrospective Studies; State Medicine | 2024 |